You are here

Article Text

Article menu
Download PDFPDF
PostScript
Featured correspondence
Aspirin and coronary artery disease
  1. Eduardo M da Rosa1,2,
  2. William C Tormen3,
  3. Edna F Lopes3
  1. 1University of Caxias do Sul, Caxias do Sul, Brazil
  2. 2Institute of Clinical Research for Multicenter Studies, Caxias do Sul, Brazil
  3. 3Medical Student at University of Caxias do Sul, Brazil
  1. Correspondence to Eduardo M da Rosa, Institute of Clinical Research for Multicenter Studies, 1130 Francisco Getulio Vargas St 95070-560, Caxias do Sul, Brazil; ipcem{at}ucs.br

https://doi.org/10.1136/hrt.2010.201137

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    To the Editor: Our ischaemic cardiopathy study group read with interest the article written by Würtz et al,1 regarding the effect of proton pump inhibitors (PPIs) on the antiplatelet effect of aspirin in …

    View Full Text

    Footnotes

    • Linked articles 201145.

    • Competing interests None.

    • Provenance and peer review Not commissioned; not externally peer reviewed.

    Linked Articles

    • PostScript
      Aspirin and coronary artery disease
      Erik Lerkevang Grove Morten Würtz Gunnar Hilmar Gislason Steen Dalby Kristensen Anne-Mette Hvas
      Heart 2010; 96 1684-1684 Published Online First: 11 Oct 2010. doi: 10.1136/hrt.2010.201145